Overview

* Select Medical ( SEM ) Q3 revenue grows 7.2%, beating analyst expectations

* Adjusted EPS for Q3 declines compared to prior year

* Company extends stock repurchase program to December 2027

Outlook

* Select Medical ( SEM ) expects 2025 revenue between $5.3 bln and $5.5 bln

* Company reaffirms 2025 Adjusted EBITDA between $510 mln and $530 mln

* Select Medical ( SEM ) raises 2025 EPS outlook to $1.14-$1.24

Result Drivers

* REHABILITATION HOSPITAL GROWTH - Revenue for the rehabilitation hospital segment increased 16.2%, contributing significantly to overall revenue growth

* CRITICAL ILLNESS RECOVERY - Revenue for the critical illness recovery hospital segment increased 4.6%, indicating modest growth

* COST MANAGEMENT - General and administrative expenses decreased by 15.4%, aiding profitability

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $1.36 $1.33

Revenue bln bln (6

Analysts

)

Q3 $111.70

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for Select Medical Holdings Corp ( SEM ) is $19.00, about 24.8% above its October 29 closing price of $14.28

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)